Table 1.

Evidence for the use of broader antifungal prophylaxis agents in childhood AML

Evidence for the use of broader antifungal prophylaxis agents in childhood AML
View large
Evidence for the use of broader antifungal prophylaxis agents in childhood AML

PC indicates prospective cohort; SCT, stem cell transplantation for leukemia; and MDS, myelodysplastic syndrome.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal